These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2980947)

  • 1. Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.
    Steele JK; Liu D; Stammers AT; Deal H; Whitney S; Levy JG
    Targeted Diagn Ther; 1988; 1():157-89. PubMed ID: 2980947
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.
    Steele JK; Liu D; Stammers AT; Whitney S; Levy JG
    Cancer Immunol Immunother; 1988; 26(2):125-31. PubMed ID: 2965972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins.
    Marches R; Mota G; Margineanu M; Stavri H; Savi G; Nicolae M; Bancu A; Moraru I
    Neoplasma; 1990; 37(5):573-8. PubMed ID: 2234217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of lymphoid and nonlymphoid tumors with monoclonal anti-Lyt-1 antibodies.
    Hollander N
    J Immunol; 1984 Nov; 133(5):2801-5. PubMed ID: 6332862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
    Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal antibodies: therapeutic possibilities and limitations].
    Tax WJ; Capel PJ; Koene RA
    Tijdschr Kindergeneeskd; 1987 Feb; 55(1):1-9. PubMed ID: 3551184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunophotodynamic therapy using the monoclonal antibody HMFG-1 linked to hematoporphyrin on MCF-7 cell in vitro.
    Prosser ES; Gleeson C; Carroll K; O'Kennedy R
    Biochem Soc Trans; 1992 Feb; 20(1):53S. PubMed ID: 1633978
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antitumor activity of bovine serum albumin-mediated conjugate of hematoporphyrin derivative with antigastric cancer monoclonal antibody].
    Zhang YJ; Wang NQ; Liu T; Dong ZW
    Yao Xue Xue Bao; 1990; 25(12):886-90. PubMed ID: 2151781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM; Stong RC; Youle RJ; Vallera DA
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumoural regulatory T cells: a potential new target in cancer immunotherapy.
    Needham DJ; Lee JX; Beilharz MW
    Biochem Biophys Res Commun; 2006 May; 343(3):684-91. PubMed ID: 16563349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
    Kirch ME; Hammerling U
    J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
    Smyth MJ; Pietersz GA; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():123-56. PubMed ID: 2979055
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.
    Gregg EO; Bridges SH; Youle RJ; Longo DL; Houston LL; Glennie MJ; Stevenson FK; Green I
    J Immunol; 1987 Jun; 138(12):4502-8. PubMed ID: 3495593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
    Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.